Evaluation of antivenom therapy for <i>Vipera palaestinae</i> bites in children: experience of two large, tertiary care pediatric hospitals

Abstract

In children, 50 ml dosing of V. palaestinae antivenom is efficacious and safe for the treatment of systemic and progressive local manifestations of envenomation by V. palaestinae.